Education
Rare disease stakeholders are a diverse group, each having very specific educational needs. Churchill's clinician-educators possess expertise in translating bench science into practical, useful information effective in improving patient ouctomes. Every program is evidence-based, measurable, and designed to answer questions about rare diseases and the role of new therapies:
- Structured feedback advisory boards
- Continuing education programs
- Clinical symposia
- Patient-oriented therapeutic administration training programs
- Print and web-based training programs
Advocacy
Rare disease advocacy groups are vibrant, influential communities of providers, patients, and caregivers. Offering information, support, and a shared voice, these groups can facilitate access to difficult-to-reach patient populations. Churchill partners with advocacy groups to enhance patient recruitment, collaborate on educational initiatives, and develop best practices guidelines.
- Disease management programs
- Web-based patient communities
- Patient recruitment
- Best practice surveys and guidelines
- Patient registries
- Collaborative educational initiatives
- Scholarship programs